Biotechnology
Compare Stocks
4 / 10Stock Comparison
CBUS vs APLD vs PGEN vs BTBT
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Biotechnology
Financial - Capital Markets
CBUS vs APLD vs PGEN vs BTBT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Biotechnology | Information Technology Services | Biotechnology | Financial - Capital Markets |
| Market Cap | $686M | $11.89B | $1.22B | $589M |
| Revenue (TTM) | $4M | $282M | $6M | $164M |
| Net Income (TTM) | $-127M | $-123M | $-247M | $137M |
| Gross Margin | 23.9% | 16.4% | 23.0% | 61.9% |
| Operating Margin | -26.8% | -31.5% | -18.6% | 16.8% |
| Forward P/E | — | — | — | 9.2x |
| Total Debt | $33M | $703M | $6M | $14M |
| Cash & Equiv. | $10M | $114M | $30M | $95M |
CBUS vs APLD vs PGEN vs BTBT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 22 | May 26 | Return |
|---|---|---|---|
| Cibus, Inc. (CBUS) | 100 | 6.8 | -93.2% |
| Applied Digital Cor… (APLD) | 100 | 1236.0 | +1136.0% |
| Precigen, Inc. (PGEN) | 100 | 312.0 | +212.0% |
| Bit Digital, Inc. (BTBT) | 100 | 90.1 | -9.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBUS vs APLD vs PGEN vs BTBT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBUS lags the leaders in this set but could rank higher in a more targeted comparison.
APLD is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 7.6% 10Y total return vs BTBT's -60.4%
- 0.0% yield, 1-year raise streak, vs BTBT's 0.3%, (2 stocks pay no dividend)
- +6.9% vs CBUS's -40.0%
PGEN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.44, Low D/E 14.3%, current ratio 4.76x
- Beta 1.44 vs BTBT's 3.37
BTBT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 3.37, yield 0.3%
- Rev growth 264.6%, EPS growth 225.0%
- Beta 3.37, yield 0.3%, current ratio 5.39x
- 264.6% NII/revenue growth vs PGEN's -36.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 264.6% NII/revenue growth vs PGEN's -36.9% | |
| Quality / Margins | 17.3% margin vs PGEN's -39.1% | |
| Stability / Safety | Beta 1.44 vs BTBT's 3.37 | |
| Dividends | 0.0% yield, 1-year raise streak, vs BTBT's 0.3%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +6.9% vs CBUS's -40.0% | |
| Efficiency (ROA) | 19.0% ROA vs PGEN's -144.1%, ROIC 6.5% vs -152.8% |
CBUS vs APLD vs PGEN vs BTBT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBUS vs APLD vs PGEN vs BTBT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BTBT leads in 3 of 6 categories
APLD leads 1 • CBUS leads 0 • PGEN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BTBT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
APLD is the larger business by revenue, generating $282M annually — 77.4x CBUS's $4M. BTBT is the more profitable business, keeping 17.3% of every revenue dollar as net income compared to PGEN's -39.1%. On growth, PGEN holds the edge at +2.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $4M | $282M | $6M | $164M |
| EBITDAEarnings before interest/tax | -$92M | -$53M | -$115M | $166M |
| Net IncomeAfter-tax profit | -$127M | -$123M | -$247M | $137M |
| Free Cash FlowCash after capex | -$51M | -$1.3B | -$76M | -$448M |
| Gross MarginGross profit ÷ Revenue | +23.9% | +16.4% | +23.0% | +61.9% |
| Operating MarginEBIT ÷ Revenue | -26.8% | -31.5% | -18.6% | +16.8% |
| Net MarginNet income ÷ Revenue | -34.9% | -43.5% | -39.1% | +17.3% |
| FCF MarginFCF ÷ Revenue | -14.1% | -4.8% | -12.0% | -65.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -12.8% | +98.2% | +2.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +55.2% | +89.4% | -11.7% | +2.8% |
Valuation Metrics
BTBT leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, BTBT's 8.5x EV/EBITDA is more attractive than APLD's 1099.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $686M | $11.9B | $1.2B | $589M |
| Enterprise ValueMkt cap + debt − cash | $709M | $12.5B | $1.2B | $508M |
| Trailing P/EPrice ÷ TTM EPS | -0.54x | -35.80x | -8.83x | 9.15x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 1099.67x | — | 8.49x |
| Price / SalesMarket cap ÷ Revenue | 188.61x | 55.16x | 309.66x | 3.60x |
| Price / BookPrice ÷ Book value/share | 31.44x | 13.18x | 28.85x | 0.56x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — |
Profitability & Efficiency
BTBT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
BTBT delivers a 21.4% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-6 for PGEN. BTBT carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBUS's 1.51x. On the Piotroski fundamental quality scale (0–9), BTBT scores 6/9 vs CBUS's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.3% | -6.2% | -5.9% | +21.4% |
| ROA (TTM)Return on assets | -38.6% | -2.3% | -144.1% | +19.0% |
| ROICReturn on invested capital | -61.5% | -7.3% | -152.8% | +6.5% |
| ROCEReturn on capital employed | -21.8% | -9.5% | -107.2% | +8.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 | 3 | 6 |
| Debt / EquityFinancial leverage | 1.51x | 1.11x | 0.14x | 0.03x |
| Net DebtTotal debt minus cash | $23M | $589M | -$24M | -$81M |
| Cash & Equiv.Liquid assets | $10M | $114M | $30M | $95M |
| Total DebtShort + long-term debt | $33M | $703M | $6M | $14M |
| Interest CoverageEBIT ÷ Interest expense | -2.49x | -2.01x | -273.83x | — |
Total Returns (Dividends Reinvested)
APLD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in APLD five years ago would be worth $85,629 today (with dividends reinvested), compared to $69 for CBUS. Over the past 12 months, APLD leads with a +691.0% total return vs CBUS's -40.0%. The 3-year compound annual growth rate (CAGR) favors APLD at 130.5% vs CBUS's -54.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -20.2% | +47.7% | -3.0% | -10.3% |
| 1-Year ReturnPast 12 months | -40.0% | +691.0% | +207.4% | -9.0% |
| 3-Year ReturnCumulative with dividends | -90.5% | +1125.1% | +232.0% | -19.7% |
| 5-Year ReturnCumulative with dividends | -99.3% | +756.3% | -36.5% | -84.6% |
| 10-Year ReturnCumulative with dividends | -99.7% | +756.3% | -84.6% | -60.4% |
| CAGR (3Y)Annualised 3-year return | -54.4% | +130.5% | +49.2% | -7.1% |
Risk & Volatility
Evenly matched — APLD and PGEN each lead in 1 of 2 comparable metrics.
Risk & Volatility
PGEN is the less volatile stock with a 1.44 beta — it tends to amplify market swings less than BTBT's 3.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APLD currently trades 93.9% from its 52-week high vs CBUS's 35.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.12x | 3.23x | 1.44x | 3.37x |
| 52-Week HighHighest price in past year | $4.19 | $44.22 | $5.23 | $4.55 |
| 52-Week LowLowest price in past year | $1.09 | $5.09 | $1.23 | $1.25 |
| % of 52W HighCurrent price vs 52-week peak | +35.8% | +93.9% | +79.3% | +40.2% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 74.4 | 62.7 | 69.1 |
| Avg Volume (50D)Average daily shares traded | 603K | 20.3M | 4.3M | 18.5M |
Analyst Outlook
Evenly matched — CBUS and APLD and BTBT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CBUS as "Buy", APLD as "Buy", PGEN as "Buy", BTBT as "Buy". Consensus price targets imply 666.7% upside for CBUS (target: $12) vs 44.6% for PGEN (target: $6). BTBT is the only dividend payer here at 0.31% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $11.50 | $61.00 | $6.00 | $5.00 |
| # AnalystsCovering analysts | 4 | 13 | 16 | 2 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | — | +0.3% |
| Dividend StreakConsecutive years of raises | 1 | 1 | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.01 | — | $0.01 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.3% | 0.0% | 0.0% |
BTBT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). APLD leads in 1 (Total Returns). 2 tied.
CBUS vs APLD vs PGEN vs BTBT: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is CBUS or APLD or PGEN or BTBT a better buy right now?
For growth investors, Bit Digital, Inc.
(BTBT) is the stronger pick with 264. 6% revenue growth year-over-year, versus -36. 9% for Precigen, Inc. (PGEN). Bit Digital, Inc. (BTBT) offers the better valuation at 9. 2x trailing P/E, making it the more compelling value choice. Analysts rate Cibus, Inc. (CBUS) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CBUS or APLD or PGEN or BTBT?
Over the past 5 years, Applied Digital Corporation (APLD) delivered a total return of +756.
3%, compared to -99. 3% for Cibus, Inc. (CBUS). Over 10 years, the gap is even starker: APLD returned +756. 3% versus CBUS's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CBUS or APLD or PGEN or BTBT?
By beta (market sensitivity over 5 years), Precigen, Inc.
(PGEN) is the lower-risk stock at 1. 44β versus Bit Digital, Inc. 's 3. 37β — meaning BTBT is approximately 134% more volatile than PGEN relative to the S&P 500. On balance sheet safety, Bit Digital, Inc. (BTBT) carries a lower debt/equity ratio of 3% versus 151% for Cibus, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — CBUS or APLD or PGEN or BTBT?
By revenue growth (latest reported year), Bit Digital, Inc.
(BTBT) is pulling ahead at 264. 6% versus -36. 9% for Precigen, Inc. (PGEN). On earnings-per-share growth, the picture is similar: Bit Digital, Inc. grew EPS 225. 0% year-over-year, compared to -20. 5% for Precigen, Inc.. Over a 3-year CAGR, APLD leads at 193. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CBUS or APLD or PGEN or BTBT?
Bit Digital, Inc.
(BTBT) is the more profitable company, earning 17. 3% net margin versus -34. 9% for Cibus, Inc. — meaning it keeps 17. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTBT leads at 16. 8% versus -34. 4% for PGEN. At the gross margin level — before operating expenses — BTBT leads at 61. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CBUS or APLD or PGEN or BTBT?
In this comparison, BTBT (0.
3% yield) pays a dividend. CBUS, APLD, PGEN do not pay a meaningful dividend and should not be held primarily for income.
07Is CBUS or APLD or PGEN or BTBT better for a retirement portfolio?
For long-horizon retirement investors, Applied Digital Corporation (APLD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+756.
3% 10Y return). Cibus, Inc. (CBUS) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (APLD: +756. 3%, CBUS: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CBUS and APLD and PGEN and BTBT?
These companies operate in different sectors (CBUS (Healthcare) and APLD (Technology) and PGEN (Healthcare) and BTBT (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CBUS is a small-cap quality compounder stock; APLD is a mid-cap high-growth stock; PGEN is a small-cap quality compounder stock; BTBT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.